MIC B Complex Injectable Compounded Drug Recall for Sterility Assurance
Talon Compounding Pharmacy is recalling MIC B Complex with Hydroxocobalamin 5MG/ML injectable vials due to lack of assurance of sterility. The recall affects vials distributed across the United States.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a compounded injectable drug involving lack of sterility assurance. Per the severity rubric, FDA Class II recalls are classified as Severe (score 4) when they involve injectable products where sterility cannot be assured, presenting risk of serious infection.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling MIC B Complex with Hydroxocobalamin 5MG/ML Injectable due to lack of assurance of sterility. The product is a prescription injectable compounded drug supplied in 6-vial containers.
The affected lot numbers are 07152021:91 (Best Use Date 10/13/2021) and 08202021:06 (Best Use Date 11/18/2021). Distribution includes the United States, Washington, D.C., and Puerto Rico.
Consumers who have received this product should contact their healthcare provider immediately. Patients should not use the recalled vials and should consult with their physician regarding alternative treatment options.
The recall was issued by the FDA as a Class II recall and is identified by recall number D-0131-2022.
The recalled product
- Product
- MIC B COMPLEX WITH HYDROXOCOBALAMIN 5MG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Category
- Drug — Compounded Injectable
- Hazard
- sterility-assurance
- contamination-risk
- injection-site-infection
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 07152021:91 BUD: 10/13/2021
- 08202021:06 BUD: 11/18/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27